The coming of age of antibiotics: discovery and therapeutic value

@article{Bush2010TheCO,
  title={The coming of age of antibiotics: discovery and therapeutic value},
  author={Karen Bush},
  journal={Annals of the New York Academy of Sciences},
  year={2010},
  volume={1213}
}
  • K. Bush
  • Published 1 December 2010
  • Medicine
  • Annals of the New York Academy of Sciences
Origins of antibiotic drug discovery are frequently traced to 1929 when Alexander Fleming recognized the antibacterial activity of a substance secreted by Penicillium notatum on a contaminated culture plate. However, the subsequent development of penicillin as a therapeutic agent was not realized until the early 1940s, after a consortium of academic and pharmaceutical scientists from England and the United States developed sufficiently advanced fermentation technology to produce high‐purity… Expand
Antibiotics from the nature - culturing of genetically talented bacterial isolates
TLDR
The current report addresses methods to activate silent genes coupled to the production of secondary metabolites through usage of microbial culture media with various composition, different culturing conditions and addition of previously reported supplements that may trigger the expression of silent metabolic pathways for novel antibiotics. Expand
Translational Modeling of Antibacterial Agents
TLDR
This new generation of mechanism-based PK/PD models will enable the exploration and increased understanding of the underlying complex mechanisms of the infectious process, and assist the transition toward systems-based approaches by integrating diverse data types and experimental platforms. Expand
Ficellomycin: an aziridine alkaloid antibiotic with potential therapeutic capacity
TLDR
This review will cover the discovery and biological activity of ficellomycin, its biosynthesis, mode of action, and related synthetic analogs, and the role of fICELLomycin and its analogs as an important source of drug prototypes will be discussed together with future research prospects. Expand
IgYs as an Alternative Approach to Antibiotics
TLDR
The reasons for antibiotic resistance in bacteria and its consequences in the field of farming and human medicine are presented, including molecular biology mechanisms and statistics, and IgYs are introduced as a promising and potential candidate for the replacement of antibiotics in the near future. Expand
Isolation and genomic characterization of bacteriophages targeting extended-spectrum cephalosporin resistant E. coli
TLDR
Comparison of the specificity of phages sourced from pig farms with and without ESC resistant bacteria suggests that highly specific phages can be sourced from locations infected and uninfected by the target bacterial isolate. Expand
Resistance drives antibacterial drug development.
TLDR
While showing some benefit, these new analogs only partially address the clinical crisis of multidrug-resistant pathogens; this is especially the case for Gram-negative bacteria. Expand
Diversity, Ecology, and Prevalence of Antimicrobials in Nature
TLDR
Subsurface sediments could yield novel antimicrobial genes, while at the same time answering important ecological questions about the microbial community, and may be an untapped repository for novel antimicrobials discovery. Expand
Mechanisms of Antibacterial Resistance: Shedding Some Light on These Obscure Processes?
TLDR
This chapter will describe the different mechanisms of bacterial resistance and the mode of action of antibiotics, aiming to contribute to the development of better treatments based on the resistance profile of each microorganism. Expand
Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria
TLDR
This review will help to illustrate different resistance mechanisms; ESBLs, carbapenemases encoded by genes carried by mobile genetic elements, which are used by Gram-negative bacteria to escape antimicrobial effect. Expand
Extracellular probiotic lipase capped silver nanoparticles as highly efficient broad spectrum antimicrobial agents
The microbial resistance to different drugs due to excessive usage of antibiotics in various domains has become a serious environmental threat in recent years. This gave the impetus to researchers toExpand
...
1
2
3
4
...

References

SHOWING 1-10 OF 36 REFERENCES
ANTIBIOTIC SUBSTANCES PRODUCED BY BACTERIA
TLDR
It is realized that only through the chemical isolation of the antibiotics concerned is it possible to completely understand the antagonistic phenomena, and four conditions have furthered their investigation. Expand
Selective Antibiotic Action of Various Substances of Microbial Origin
TLDR
Since Pasteur first demonstrated that certain micro6rganisms are able to exert antagonistic or antibiotic effects upon other organisms, an extensive literature has accumulated and certain facts have now become recognized concerning the nature of the phenomenon produced by antagonistic microorganisms. Expand
Challenges of antibacterial discovery revisited
TLDR
Implementing multiple screening and target identification strategies is recommended for improving the likelihood of discovering new antibacterial compounds that address unmet needs, particularly by the identification of new antibiotic classes with improved tractability and by expanding the predictability of in vitro safety assays. Expand
STREPTOMYCIN IN TREATMENT OF CLINICAL AND EXPERIMENTAL TUBERCULOSIS
TLDR
It is appropriate to discuss streptomycin at this time, which represents the second anniversary of the announcement of the discovery of this remarkable antibiotic substance, which has resulted in a renewal of the chemotherapeutic attack against tuberculosis. Expand
PRODUCTION OF ANTIBIOTIC SUBSTANCES BY ACTINOMYCETES *†
It has now been definitely established that a considerable proportion of all actinomycetes that can be isolated from soils or other natural substrates have the capacity of inhibiting the growth of,Expand
ANTIBIOTIC SUBSTANCES—CONTRIBUTION OF THE MICROBIOLOGIST *
  • S. Waksman
  • Medicine
  • Annals of the New York Academy of Sciences
  • 2010
TLDR
It is sufficient to mention, for example, the chemistry of the antibiotics, other than penicillin, the mode of action of antibiotics upon bacteria, the increased resistance of bacterial strains to a given antibiotic, and others. Expand
Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.
TLDR
A new beta-lactam antibiotic, named thienamycin, was discovered in culture broths of Streptomyces MA4297, and subsequently determined to be a hitherto unrecognized species, is designated StrePTomyces cattleya (NRRL 8057). Expand
STREPTOMYCIN AND STREPTOTHRICIN: THE ABSORPTION, EXCRETION, AND CHEMOTHERAPEUTIC PROPERTIES
From the reports on the pharmacological and pathological effects produced in animals, following streptomycin and streptothricin administration, it is evident that the toxicity of these two substancesExpand
Structure‐based design of anti‐infectives
TLDR
This review explores the exciting opportunities for antimalarial, antiviral, and antibacterial drug discovery arising from the new paradigm of structure‐based drug design. Expand
The interface between veterinary and human antibiotic use
TLDR
The interface between veterinary and human antibiotic use and resistance, especially with respect to human microbial food safety, has begun to redirect the industry pipeline of novel antimicrobial agents to be commercialized for use in veterinary medicine. Expand
...
1
2
3
4
...